Proton therapy is a technologically advanced form of radiation treatment that can deliver required doses of radiation. It takes just minutes to deliver a high level of radiation in a number of treatment sessions. Proton therapy uses accelerated subatomic particles called protons to send a high level of energy directly to the tumor site through a magnetically-guided beam. In proton therapy, particles of proton are accelerated to about two-thirds the speed of light, or more than 100,000 miles per second, to destroy cancer cells. Proton therapy differs from traditional radiation therapy in the way energy is delivered to a patient. Advantages of proton therapy are lower risk of treatment induced disorders, better quality of life during and after treatment, precise dose delivery, and fewer side effects than intensity modulated radiotherapy (IMRT). Proton therapy is effective for both adult and pediatric patients. The two types of proton delivery systems are pencil beam scanning and passive scattering. Pencil beam scanning employs 3D images to determine the tumor's exact location, allowing therapy delivery to that precise shape, size, and depth. According to the World Health Organization, cancer is a leading cause of death worldwide and cancer deaths are expected to continue to rise to over 13.1 million by 2030.
Rise in prevalence of cancer patients, growing awareness among people, improvement in insurance coverage for proton therapy, increase in consumption of tobacco, and surge in demand for proton therapy are factors driving the global proton therapy market. Tobacco use is associated with increased risk of several cancers including lung, oral cavity, pharynx, bladder, esophagus, kidney, liver, stomach, larynx, pancreas, bowel, cervix, leukemia, and ovarian. According to the World Health Organization, in 2015, over 1.1 billion people smoked tobacco and the number continues to rise. Technological advancements and increase in health care expenditure are the other factors fueling the growth of the global proton therapy market. However, high treatment cost is a major restraint of the global proton therapy market.
The global proton therapy market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be classified into single room systems and multi room systems. Based on application, the global proton therapy market can be categorized into breast cancer, brain cancer, prostate cancer, lung cancer, and others. In terms of end-user, the market can be divided into hospitals, specialty clinics, and ambulatory surgery centers
In terms of region, the global proton therapy market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the global proton therapy market due to technological advancements, rise in prevalence of cancer patients, and growing adoption for treatment procedure. According to the American Cancer Society, about 1,688,780 new cancer cases are expected to be diagnosed in the U.S. in 2017. Europe is the second largest market for proton therapy. Increasing use of tobacco is the key factor driving the proton therapy market in the region. According to Eurostat, one in four EU citizens over 15 years old (24%) is a tobacco smoker. The market in Asia Pacific is expected to expand at a higher growth rate due to growing awareness among people, large target population, and increase in health care expenditure. According to the World Health Organization, nearly 70% deaths due to cancer occur in low- and middle-income countries.
Major players operating in the proton therapy market include Mevion Medical Systems, Inc., IBA Worldwide, ProTom International, Inc., Varian Medical Systems, Inc., Hitachi, Ltd., and Mitsubishi Electric Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
